FSMAX
Price
$117.72
Change
-$0.65 (-0.55%)
Updated
Jul 2 closing price
Net Assets
43.48B
TMIFX
Price
$9.59
Change
-$0.16 (-1.64%)
Updated
Jul 2 closing price
Net Assets
139.42M
Interact to see
Advertisement

FSMAX vs TMIFX

FSMAX vs TMIFX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. TMIFX commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and TMIFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 43.5B vs. TMIFX (139M). FSMAX pays higher dividends than TMIFX: FSMAX (0.48) vs TMIFX (0.00). FSMAX was incepted earlier than TMIFX: FSMAX (15 years) vs TMIFX (25 years). TMIFX (1.10) is less costly to investors than FSMAX (0.04). TMIFX is a more actively managed with annual turnover of: 109.00 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than TMIFX: FSMAX (0) vs TMIFX (5000). FSMAX annual gain was more profitable for investors over the last year : 25.67 vs. TMIFX (-14.37). FSMAX return over 5 years is better than : 35.59 vs. TMIFX (-34.58).
FSMAXTMIFXFSMAX / TMIFX
Total Expense Ratio0.040.954%
Annual Report Gross Expense Ratio0.041.103%
Fund Existence15 years25 years-
Gain YTD16.93710.357164%
Front LoadN/AN/A-
Min. Initial Investment05000-
Min. Initial Investment IRAN/AN/A-
Net Assets43.5B139M31,295%
Annual Yield % from dividends0.480.00-
Returns for 1 year25.67-14.37-179%
Returns for 3 years68.7616.10427%
Returns for 5 years35.59-34.58-103%
Returns for 10 years149.51-23.13-646%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCFX52.811.51
+2.94%
Rydex Biotechnology C
TIEUX17.070.24
+1.43%
Morgan Stanley Pathway Intl Eq
CAIBX82.560.77
+0.94%
American Funds Capital Inc Bldr A
TRMSX25.04-0.10
-0.40%
T. Rowe Price Mid-Cap Index I
PRJDX40.44-0.76
-1.84%
PGIM Jennison Global Opportunities R4